SunRock Biopharma y Escugen han iniciado una colaboración estratégica para codesarrollar SRB123, un conjugado anticuerpo-fármaco (ADC, por sus siglas en inglés) first-in-class dirigido contra el r...
Read moreEl proyecto propone la inhibición de las proteínas ETV4 y ETV5, miembros de la familia PEA3, como complemento a los inhibidores de KRAS. El objetivo es superar la resistencia que limita la eficacia ...
Read morePatients with Chronic Obstructive Pulmonary Disease (COPD) who suffer from sarcopenia, meaning a loss of strength and muscle capacity, show higher levels of a protein linked to muscle growth regulatio...
Read moreInvestigadores del Cima Universidad de Navarra descubren que la administración de reguladores epigenéticos e inductores de muerte celular prolonga la supervivencia en modelos animales de cáncer
Read moreOncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions
Read moreSmoking is declining in many parts of the world, but statistics warn of an increase in cases of lung cancer among non-smokers. These findings point to pollution as a possible cause.
Read moreResearchers have managed to identify biomarkers for cognitive impairment in this group of patients that could help in its diagnosis.
Read moreConcluyen que aunque no existen diferencias significativas en el número de pacientes que mejoraron el daño pulmonar provocado por un síndrome de dificultad respiratoria aguda inducido por Covid-19 ...
Read moreEl estudio revela que este serotipo se ha convertido en una de las principales causas de enfermedad neumocócica invasiva en España, tanto en adultos como en población pediátrica. El aumento se deb...
Read moreThe study shows that resistant strains persist despite conjugate vaccines and warns of worse outcomes in people with a poor prognosis treated with amoxicillin.
Read moreTreatment with durvalumab, a PD-L1 inhibitor monoclonal antibody, has become established recently as the standard therapy for patients with unresectable stage III non-small cell lung cancer (NSCLC) wh...
Read moreA new European study, published in The Lancet Regional Health - Europe and conducted as part of the EXPANSE project, is the first to show how multiple components of the so-called urban exposome (urban...
Read more